Gee Madam..I didn't realize you have such insight to the board of TEVA...I see your propheric powers are coming back...
I was thinking maybe /could have something to do with the following:
(1) the fact that REVASCOR was the most expensive R& D program in their history ( at $150m +) ..not in the decade but history. TEVA are used to spending sub $50m on R & D ( there are generic company ..as you know).
(2) when they worked out the massive scale up in Sales & Distribution set up costs which would be incurred when no Cardio franchise exists
(3) focusing on completing a $40bn deal.
I think Dolce inferred , the Teva downline staff running the CHF trials may have had a different view. But the board make a decision based on effective use and allocation of scarce resources (particularly in funding the massive debt Teva are taking on in completing Allegan deal) ...
... bottom line..your a funny fella madam...real funny !! (particularly when you become verrry serious and are on to of your game)
Best,
- Forums
- ASX - By Stock
- MSB
- Ann: Update on Heart Failure Trial and Funding of Operations-MSB.AX
Ann: Update on Heart Failure Trial and Funding of Operations-MSB.AX, page-97
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 94863 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 5000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 85863 | 1.125 |
3 | 60500 | 1.120 |
3 | 49858 | 1.115 |
10 | 234700 | 1.110 |
3 | 20500 | 1.105 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 1000 | 1 |
1.135 | 15000 | 2 |
1.140 | 10000 | 1 |
1.150 | 27892 | 3 |
1.155 | 25000 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |